James Cleary; Chief Financial Officer, Executive Vice President; Cencora Inc Hello, everyone, and thank you for joining the Cencora fiscal 2025 second-quarter results conference call. My name is Lucy, ...

Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion ...

We recently published a list of Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks In this article, we ...

Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ETCompany ParticipantsBennett Murphy - Senior Vice President, Head of ...

The legislation would ensure Medicare beneficiaries have access to care and services provided by pharmacists within state ...

The legislation would ensure Medicare beneficiaries have access to care and services provided by pharmacists within state ...

Cencora COR has outperformed the market over the past 5 years by 12.25% on an annualized basis producing an average annual return of 25.82%. Currently, Cencora has a market capitalization of $55. ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

FILE - A Walgreens logo is seen from the exterior of a store in Wheeling, Ill., Oct. 15, 2024. (AP Photo/Nam Y. Huh, file) Walgreens has agreed to pay up to $350 million in a settlement with the U ...

(The Hill) – National pharmaceutical retailer Walgreens has agreed to pay at least $300 million to settle allegations it illegally fulfilled millions of invalid controlled substance ...

Has Cencora (COR) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Cencora is a member of our Medical group, which includes 1002 ...